FDA Investigator Gina M Brackett
Gina M Brackett has conducted inspections on 28 sites in 1 countries as of 26 Sep 2005. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
28
Last Inspection Date:
26 Sep 2005
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gina M Brackett:
Allison C Hunter,
Allison M Mcgloin,
Allison M Scheck,
Amber M Capello Jones,
Anna M Brannen,
Arie R Dyk,
Brigitte K Hofmann,
Brigitte Kh Strelnik,
Bryan J Love,
Christina L Bigham,
Christine E Kelley,
Christopher A Demitrius,
Cynthia T Cain,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Genevieve E Ghand,
James G Marsh,
Javonica F Penn,
Jerry J Corwin,
Joseph X Kaufman,
Laureen M Geniusz,
Lindsey M Schwierjohann,
Lori A Carr,
Lori A Lahmann,
Maribeth G Grattan,
Maribeth G Niesen,
Mark E Parmon,
Matt D Suedkamp,
Michael E Campbell,
Michael J Schibi,
Michael K Larson,
Michael P Sheehan,
Monica J Wilkins,
Moseley Fulcher,
Nicholas L Paulin,
Nisha C Patel,
Phillip M Pontikos,
Robbie J Alleman,
Robert Sharpnack,
Rosanna M Goodrich,
Roy C Stephens,
Shannon A Gregory,
Steven P Eastham,
Teresa K Kastner,
Thomas C Woods,
Thomas W Nojek,
Thunder N Dunkijacobs,
Tiki J Dixon,
Tracey L Harris,
Troy A Huffman
Gina M Brackett's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2005 | FDA 483 | Ferno-Washington Inc - Form 483, 2005-09-30 |
August, 2002 | FDA 483 | Meridian Bioscience Inc - Form 483, 2002-08-27 |
September, 2005 | FDA 483 Response | Ferno-Washington Inc - Form 483R, 2005-10-28 |
March, 2001 | EIR | Robert Osher MD - EIR, 2001-03-19 |
July, 2002 | EIR | Ethicon Endo-Surgery Inc - EIR, 2002-07-17 |
August, 2001 | FDA 483 | John P. Tuttle, Jr., MD. - Form 483, 2001-08-07 |
January, 2001 | FDA 483 | Meridian Bioscience Inc - Form 483, 2001-01-17 |
January, 2002 | FDA 483 | DM Medical Inc - Form 483, 2002-01-30 |
February, 2000 | EIR | Evan A Stein MD - EIR, 2000-02-08 |
February, 2002 | FDA 483 | Chester Packaging LLC - Form 483, 2002-02-25 |
March, 2001 | FDA 483 | Robert Osher MD - Form 483, 2001-03-19 |
March, 2001 | FDA 483 Response | Robert Osher MD - Form 483R, 2001-04-03 |
January, 2001 | FDA 483 Response | Meridian Bioscience Inc - Form 483R, 2001-02-09 |
May, 2002 | EIR | Ethicon Endo-Surgery Inc - EIR, 2002-05-29 |
August, 2001 | EIR | John Tuttle MD - EIR, 2001-08-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more